Combination therapy including TNF-inhibitors along with an older drug known as methotrexate (MTX) can slash the risk of heart attack in people with rheumatoid arthritis (RA).
People with rheumatoid arthritis (RA) who are overweight or obese may be less likely to go into remission when they are treated with a combination of conventional disease modifying anti-rheumatic drugs (DMARDs) and steroids than their thinner counterparts, a study shows.
The number of bleeding ulcers and other gastrointestinal complications has increased since a class of pain drugs called Cox-2 inhibitors fell out of favor due to their increased risk of heart attack or stroke, according to a new study.